dpp4 vs glp 1 Prescribing pearls: A guide to DPP-4 inhibitors (gliptins) Role of DPP-4 Inhibitors in

Arenas J, Ricoy JR, Encinas AR, Pola P, D'Iddio S, Zeviani M, Didonato S, Corsi M

3 Results 3.1 Trial Population Between August 2016 and September 2018, 193 participants were randomized and received at least one dose of the randomized treatment (Fig

Stroncek, J

The more cautious interpretation is that patients who receive GLP-1 receptor agonists may differ in important but incompletely measured ways from those treated with insulin or metformin, including overall health, treatment access, healthcare follow-up, or cardiometabolic care intensity

MPGF, Major proglucagon fragment

doi: 10.1001/jamanetworkopen.2021.0242 4 SuwanchatchaiCBuaphanSKhuanchareeK